Zhu, L.; Mu, Q.; Yu, J.; Griffin, J.I.; Xu, X.; Ho, R.J.Y.
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models. Pharmaceutics 2022, 14, 89.
https://doi.org/10.3390/pharmaceutics14010089
AMA Style
Zhu L, Mu Q, Yu J, Griffin JI, Xu X, Ho RJY.
ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models. Pharmaceutics. 2022; 14(1):89.
https://doi.org/10.3390/pharmaceutics14010089
Chicago/Turabian Style
Zhu, Linxi, Qingxin Mu, Jesse Yu, James I. Griffin, Xiaolin Xu, and Rodney J. Y. Ho.
2022. "ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models" Pharmaceutics 14, no. 1: 89.
https://doi.org/10.3390/pharmaceutics14010089
APA Style
Zhu, L., Mu, Q., Yu, J., Griffin, J. I., Xu, X., & Ho, R. J. Y.
(2022). ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models. Pharmaceutics, 14(1), 89.
https://doi.org/10.3390/pharmaceutics14010089